Your browser doesn't support javascript.
loading
Host defense against the infection of Klebsiella pneumoniae: New strategy to kill the bacterium in the era of antibiotics?
Liang, Zihan; Wang, Yiyao; Lai, Yixiang; Zhang, Jingyi; Yin, Lanlan; Yu, Xiang; Zhou, Yongqin; Li, Xinzhi; Song, Yinhong.
Afiliação
  • Liang Z; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.
  • Wang Y; Institute of Infection and Inflammation, China Three Gorges University, Yichang, China.
  • Lai Y; College of Basic Medical Science, China Three Gorges University, Yichang, China.
  • Zhang J; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.
  • Yin L; Institute of Infection and Inflammation, China Three Gorges University, Yichang, China.
  • Yu X; College of Basic Medical Science, China Three Gorges University, Yichang, China.
  • Zhou Y; Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.
  • Li X; Institute of Infection and Inflammation, China Three Gorges University, Yichang, China.
  • Song Y; College of Basic Medical Science, China Three Gorges University, Yichang, China.
Front Cell Infect Microbiol ; 12: 1050396, 2022.
Article em En | MEDLINE | ID: mdl-36506034
ABSTRACT
Klebsiella pneumoniae (K. pneumoniae) is a typical gram-negative iatrogenic bacterium that often causes bacteremia, pneumonia and urinary tract infection particularly among those with low immunity. Although antibiotics is the cornerstone of anti-infections, the clinical efficacy of ß-lactamase and carbapenems drugs has been weakened due to the emergence of drug-resistant K. pneumoniae. Recent studies have demonstrated that host defense plays a critical role in killing K. pneumoniae. Here, we summarize our current understanding of host immunity mechanisms against K. pneumoniae, including mechanical barrier, innate immune cells, cellular immunity and humoral immunity, providing a theoretical basis and the new strategy for the clinical treatment of K. pneumoniae through improving host immunity.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Klebsiella pneumoniae / Antibacterianos Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Klebsiella pneumoniae / Antibacterianos Idioma: En Revista: Front Cell Infect Microbiol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China